Impact of mTOR Inhibitors on Cancer Development in Kidney Transplantation Recipients: A Population-Based Study

This publication has 22 references indexed in Scilit:

• Death from cancer: a sobering truth for patients with kidney transplants
  Kidney International, 2014
• Switch to a Sirolimus‐Based Immunosuppression in Long‐Term Renal Transplant Recipients: Reduced Rate of (Pre‐)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor‐Blinded, Controlled Clinical Trial
  American Journal of Transplantation, 2010
• Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation
  Journal of the American Society of Nephrology, 2010
• Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
  Transplantation, 2009
• Cancer Incidence Before and After Kidney Transplantation
  JAMA, 2006
• Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation
  Journal of the American Society of Nephrology, 2006
• Two‐year incidence of malignancy in sirolimus‐treated renal transplant recipients: results from five multicenter studies*
  Clinical Transplantation, 2004
• Malignancy in Renal Transplantation
  Journal of the American Society of Nephrology, 2004
• Causes of death after renal transplantation
  Nephrology Dialysis Transplantation, 2001
• Long-term survival in renal transplant recipients with graft function
  Kidney International, 2000